Cerenis raises EUR 42.1 million

Cholesterol company Cerenis (Toulouse, France) raised EUR 42.1 million ($53.5 million) in a series B round led by TVM. New investor OrbiMed joined existing investors Sofinnova Partners; HealthCap; Alt...